Loading clinical trials...

UNKNOWN

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

NCT02887781•University Hospital, Brest

Summary

This study aims to investigate the factors (clinical, care-related and genetic) affecting renal outcome in patients with TSC (Tuberous sclerosis complex)

Eligibility

Age

8 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient presenting with an isolated angiomyolipoma or
•Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or
•Patient presenting with tuberous sclerosis complex
•Patient not objecting to the study

Exclusion Criteria

•■Patient objecting to the study

Locations (2)

CHU Brest

Brest, France

CHU Rennes

Rennes, France

Key Dates

Start Date

August 13, 2015

Primary Completion Date

December 31, 2024

Completion Date

December 31, 2024

Last Updated

January 5, 2024

Enrollment

150

ESTIMATED participants

Conditions

Tuberous Sclerosis Complex

Contacts

Yannick LE MEUR, MD PhD

CONTACT

yannick.lemeur@chu-brest.fr

TANDem-2: Closing the Gap to Interventions for TAND

NCT06879665

Adult Caregivers of Individuals With TSCTuberous Sclerosis Complex (TSC)

View study

ACTIVE_NOT_RECRUITING

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

NCT04198181

Tuberous Sclerosis ComplexEpilepsy

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

Inclusion Criteria

Exclusion Criteria

TANDem-2: Closing the Gap to Interventions for TAND

The Effectiveness and Safety of Resective Epilepsy Surgery for TRE

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex

Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants

Acceptance and Commitment Therapy in Tuberous Sclerosis Complex